Radost Vatcheva

3.3k total citations · 1 hit paper
19 papers, 2.2k citations indexed

About

Radost Vatcheva is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Radost Vatcheva has authored 19 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in Radost Vatcheva's work include Genomic variations and chromosomal abnormalities (5 papers), Cancer Genomics and Diagnostics (4 papers) and Genomics and Chromatin Dynamics (4 papers). Radost Vatcheva is often cited by papers focused on Genomic variations and chromosomal abnormalities (5 papers), Cancer Genomics and Diagnostics (4 papers) and Genomics and Chromatin Dynamics (4 papers). Radost Vatcheva collaborates with scholars based in United Kingdom, United States and Spain. Radost Vatcheva's co-authors include Rachael Natrajan, Jorge S. Reis‐Filho, Christopher J. Lord, Alan Ashworth, Rachel Brough, Jeff Boyd, Douglas A. Levine, Stacey L. Edwards, Denise Sheer and Alan Mackay and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Radost Vatcheva

19 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resistance to therapy caused by intragenic deletion in BRCA2

2008 754 citations Stacey L. Edwards, Rachel Brough et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Radost Vatcheva United Kingdom	16	1.6k	974	510	459	195	19	2.2k
Tatiana Popova France	20	1.5k 1.0×	831 0.9×	532 1.0×	899 2.0×	118 0.6×	39	2.4k
Louise J. Barber United Kingdom	20	1.7k 1.1×	690 0.7×	270 0.5×	499 1.1×	139 0.7×	29	2.1k
Rachel Brough United Kingdom	21	2.4k 1.5×	2.1k 2.1×	480 0.9×	448 1.0×	93 0.5×	39	3.1k
Céline Jacquemont United States	13	1.2k 0.7×	994 1.0×	347 0.7×	293 0.6×	53 0.3×	22	1.6k
Vijay S. Tonk United States	21	1.2k 0.7×	342 0.4×	689 1.4×	250 0.5×	162 0.8×	72	1.9k
Ioannis Assiotis United Kingdom	12	1.0k 0.6×	699 0.7×	274 0.5×	244 0.5×	79 0.4×	14	1.4k
Katrien Berns Netherlands	15	2.2k 1.4×	1.2k 1.3×	236 0.5×	537 1.2×	50 0.3×	19	3.0k
E. Marielle Hijmans Netherlands	17	2.5k 1.6×	1.7k 1.7×	406 0.8×	518 1.1×	58 0.3×	20	3.4k
Anna V. Roschke United States	20	1.2k 0.8×	458 0.5×	477 0.9×	317 0.7×	204 1.0×	27	1.9k
Kalindi Parmar United States	28	2.1k 1.3×	862 0.9×	273 0.5×	586 1.3×	85 0.4×	60	3.0k

Countries citing papers authored by Radost Vatcheva

Since Specialization

Citations

This map shows the geographic impact of Radost Vatcheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radost Vatcheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radost Vatcheva more than expected).

Fields of papers citing papers by Radost Vatcheva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radost Vatcheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radost Vatcheva. The network helps show where Radost Vatcheva may publish in the future.

Co-authorship network of co-authors of Radost Vatcheva

This figure shows the co-authorship network connecting the top 25 collaborators of Radost Vatcheva. A scholar is included among the top collaborators of Radost Vatcheva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radost Vatcheva. Radost Vatcheva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Brough, Rachel, Ilirjana Bajrami, Radost Vatcheva, et al.. (2012). APRIN is a cell cycle specific BRCA2‐interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer. The EMBO Journal. 31(5). 1160–1176. 58 indexed citations

Lambros, Maryou, Paul M Wilkerson, Rachael Natrajan, et al.. (2011). High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform. Laboratory Investigation. 91(10). 1491–1501. 14 indexed citations

Dedes, Konstantin J., Daniel Wetterskog, Ana M. Mendes‐Pereira, et al.. (2010). PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors. Science Translational Medicine. 2(53). 53ra75–53ra75. 207 indexed citations

Dedes, Konstantin J., Felipe C. Geyer, Maryou B. Lambros, et al.. (2010). Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Research and Treatment. 124(3). 653–666. 26 indexed citations

Natrajan, Rachael, Daniel Wetterskog, Maryou Lambros, et al.. (2010). Abstract 2138: Functional characterization of the 19q12 amplicon in grade 3 breast cancers. Cancer Research. 70(8_Supplement). 2138–2138. 2 indexed citations

Klingbeil, Pamela, Rachael Natrajan, Radost Vatcheva, et al.. (2009). CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Research and Treatment. 120(1). 95–109. 51 indexed citations

Geyer, Felipe C., Britta Weigelt, Rachael Natrajan, et al.. (2009). Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. The Journal of Pathology. 220(5). 562–573. 155 indexed citations

Natrajan, Rachael, Britta Weigelt, Alan Mackay, et al.. (2009). An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Research and Treatment. 121(3). 575–589. 125 indexed citations

Natrajan, Rachael, Maryou B. Lambros, Felipe C. Geyer, et al.. (2009). Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?. Genes Chromosomes and Cancer. 48(4). 351–365. 58 indexed citations

10.

Edwards, Stacey L., Rachel Brough, Christopher J. Lord, et al.. (2008). Resistance to therapy caused by intragenic deletion in BRCA2. Nature. 451(7182). 1111–1115. 754 indexed citations breakdown →

11.

Takousis, Petros, Jill Williamson, Peter Sasieni, et al.. (2007). Replication Timing Profile Reflects the Distinct Functional and Genomic Features of the MHC Class II Region. Cell Cycle. 6(19). 2393–2398. 4 indexed citations

12.

Rowe, Janice, Radost Vatcheva, Darren Heavens, et al.. (2003). Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell. 4(4). 301–310. 81 indexed citations

13.

Donev, Rossen, Roger W. Horton, Stephan Beck, et al.. (2003). Recruitment of Heterogeneous Nuclear Ribonucleoprotein A1in Vivo to the LMP/TAP Region of the Major Histocompatibility Complex. Journal of Biological Chemistry. 278(7). 5214–5226. 19 indexed citations

14.

Shiels, Carol, Suhail A. Islam, Radost Vatcheva, et al.. (2001). PML bodies associate specifically with the MHC gene cluster in interphase nuclei. Journal of Cell Science. 114(20). 3705–3716. 104 indexed citations

15.

Volpi, Emanuela V., Edith Chevret, T. Alwyn Jones, et al.. (2000). Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. Journal of Cell Science. 113(9). 1565–1576. 369 indexed citations

16.

Flomen, Rachel, Radost Vatcheva, Patricia Gorman, et al.. (1998). Construction and Analysis of a Sequence-Ready Map in 4q25: Rieger Syndrome Can Be Caused by Haploinsufficiency ofRIEG, but Also by Chromosome Breaks ≈90 kb Upstream of This Gene. Genomics. 47(3). 409–413. 49 indexed citations

17.

Nižetić, Dean, Renata M. J. Hamvas, Richard Mott, et al.. (1994). An integrated YAC-overlap and ‘cosmid-pocket’ map of the human chromosome 21. Human Molecular Genetics. 3(5). 759–770. 63 indexed citations

18.

Ross, Mark T., Dean Nižetić, Catherine Nguyen, et al.. (1992). Selection of a human chromosome 21 enriched YAC sub–library using a chromosome–specific composite probe. Nature Genetics. 1(4). 284–290. 15 indexed citations

19.

Baldini, Antonio, Mark Ross, Dean Nižetić, et al.. (1992). Chromosomal assignment of human YAC clones by fluorescence in Situ hybridization: Use of single-yeast-colony PCR and multiple labeling. Genomics. 14(1). 181–184. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact